From: Is the thymidine labeling index a good prognostic marker in breast cancer?
5-year DFS rate (%) | P-value | 5-year OS rate (%) | P-value | |
---|---|---|---|---|
Patients with adjuvant chemotherapy (n = 205) | 0.272 | 0.224 | ||
Low TLI | 75 | 89 | ||
High TLI | 68 | 80 | ||
Patients without adjuvant chemotherapy (n = 63) | 0.663 | 0.634 | ||
Low TLI | 83 | 95 | ||
High TLI | 89 | 96 | ||
Patients with adjuvant hormonal therapy(n = 187) | 0.512 | 0.824 | ||
Low TLI | 79 | 89 | ||
High TLI | 78 | 89 | ||
Patients without adjuvant hormonal therapy (n = 81) | 0.933 | 0.164 | ||
Low TLI | 69.4 | 88.9 | ||
High TLI | 63.5 | 74.4 | ||
Patients with stage I (n = 54) | 0.474 | 0.05 | ||
Low TLI | 88.2 | 100 | ||
High TLI | 78.7 | 76.4 | ||
Patients with stage II (n = 138) | 0.464 | 0.070 | ||
Low TLI | 79.8 | 95.4 | ||
High TLI | 74.2 | 89.7 | ||
Patients with stage III (n = 76) | 0.526 | 0.800 | ||
Low TLI | 65.7 | 76.3 | ||
High TLI | 63.2 | 73.4 | ||
Patients with node-negative disease (n = 114) | 0.994 | 0.188 | ||
Low TLI | 83.5 | 92.6 | ||
High TLI | 86.1 | 88.6 | ||
Patients with node-positive disease (n = 154) | 0.142 | 0.113 | ||
Low TLI | 72.6 | 86.4 | ||
High TLI | 61.2 | 73.6 |